Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture-Reference-Cited by-同舟云学术

Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture

Published:2018-05-09 Issue:8 Volume:33 Page:1422-1434
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Sing Chor-Wing¹,Wong Angel YS¹,Kiel Douglas P²,Cheung Elaine YN³,Lam Joanne KY⁴,Cheung Tommy T⁵,Chan Esther W¹,Kung Annie WC⁵,Wong Ian CK¹⁶,Cheung Ching-Lung¹⁵⁷⁸

Affiliation:

1. Department of Pharmacology and Pharmacy; Li Ka Shing Faculty of Medicine; The University of Hong Kong; Pokfulam Hong Kong

2. Institute for Aging Research; Hebrew SeniorLife and Department of Medicine Beth Israel Deaconess Medical Center and Harvard Medical School; Boston USA

3. Department of Medicine and Geriatrics; United Christian Hospital; Kwun Tong Hong Kong

4. Department of Medicine; Queen Mary Hospital; Pokfulam Hong Kong

5. Department of Medicine; Li Ka Shing Faculty of Medicine; The University of Hong Kong; Pokfulam Hong Kong

6. Research Department of Practice and Policy; School of Pharmacy; University College London; London UK

7. The State Key Laboratory of Pharmaceutical Biotechnology; Li Ka Shing Faculty of Medicine; The University of Hong Kong; Pokfulam Hong Kong

8. Centre for Genomic Sciences; Li Ka Shing Faculty of Medicine; The University of Hong Kong; Pokfulam Hong Kong

Funder

RGC and HMRF

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.3448/fullpdf

Reference49 articles.

1. Hip fracture and risk of acute myocardial infarction: a nationwide study;Chiang;J Bone Miner Res,2013

2. Increased risk of stroke in the year after a hip fracture: a population-based follow-up study;Kang;Stroke,2011

3. Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study;Cameron;J Bone Miner Res,2010

4. Potential mediators of the mortality reduction with zoledronic acid after hip fracture;Colon-Emeric;J Bone Miner Res,2010

5. 2017 https://www.nice.org.uk/guidance/ta161/uptake

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events;Nature Communications;2024-05-22

2. An integrated multi-omics analysis reveals osteokines involved in global regulation;Cell Metabolism;2024-05

3. Positive und negative (Neben)Effekte bei Osteoporose-Sequenztherapie;Osteologie;2024-05

4. Low Bone Mineral Density as a Risk Factor for Liver Cirrhosis;The Journal of Clinical Endocrinology & Metabolism;2024-04-04

5. Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells;Frontiers in Endocrinology;2024-04-04